ConductScience.org, home

Paper35004331

The Role of Sphingolipids Metabolism in Cancer Drug Resistance.

Bataller M and 5 others. Front Oncol, 2021. Cited by 53 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The Role of Sphingolipids Metabolism in Cancer Drug Resistance. Papers, record 35004331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35004331

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Role of Sphingolipids Metabolism in Cancer Drug Resistance.
PubMed
Journal
Front Oncol
PubMed
Year
2021
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
53
iCite
Relative citation ratio, by iCite
3.53
iCite
Revised in PubMed
2022-01-11
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bataller MMarina
2Sánchez-García AAlmudena
3Garcia-Mayea YYoelsis
4Mir CCristina
5Rodriguez IIsabel
6LLeonart MEMatilde Esther

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References122

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19813079Differential effects of sphingomyelin hydrolysis and cholesterol transport on oxysterol-binding protein phosphorylation and Golgi localization.J Biol Chem1998https://conductscience.org/library/papers/9813079PubMed
225320006Phenotype switching: tumor cell plasticity as a resistance mechanism and target for therapy.Cancer Res2014https://conductscience.org/library/papers/25320006PubMed
334516706Crucial role of glucosylceramide synthase in the regulation of stem cell-like cancer cells in B16F10 murine melanoma.Mol Carcinog2021https://conductscience.org/library/papers/34516706PubMed
414689449Regulation of sphingomyelinases in cells of the oligodendrocyte lineage.J Neurosci Res2004https://conductscience.org/library/papers/14689449PubMed
521527515Sphingosine kinase-1 and sphingosine 1-phosphate receptor 2 mediate Bcr-Abl1 stability and drug resistance by modulation of protein phosphatase 2A.Blood2011https://conductscience.org/library/papers/21527515PubMed
619521959Sphingosine kinase 1 inhibition sensitizes hormone-resistant prostate cancer to docetaxel.Int J Cancer2009https://conductscience.org/library/papers/19521959PubMed
718058224Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer.Breast Cancer Res Treat2008https://conductscience.org/library/papers/18058224PubMed
812401200Sphingomyelinases: enzymology and membrane activity.FEBS Lett2002https://conductscience.org/library/papers/12401200PubMed
922074005Proteomic approach reveals FKBP4 and S100A9 as potential prediction markers of therapeutic response to neoadjuvant chemotherapy in patients with breast cancer.J Proteome Res2012https://conductscience.org/library/papers/22074005PubMed
1029348854Acid ceramidase and its inhibitors: a de novo drug target and a new class of drugs for killing glioblastoma cancer stem cells with high efficiency.Oncotarget2017https://conductscience.org/library/papers/29348854PubMed
1128445970Acid ceramidase is a novel drug target for pediatric brain tumors.Oncotarget2017https://conductscience.org/library/papers/28445970PubMed
1211114522An oncogenic role of sphingosine kinase.Curr Biol2000https://conductscience.org/library/papers/11114522PubMed
138379450Metabolic effects of inhibiting glucosylceramide synthesis with PDMP and other substances.Adv Lipid Res1993https://conductscience.org/library/papers/8379450PubMed
1425763355Phenotype switching in melanoma: implications for progression and therapy.Front Oncol2015https://conductscience.org/library/papers/25763355PubMed
1529071215The Different Mechanisms of Cancer Drug Resistance: A Brief Review.Adv Pharm Bull2017https://conductscience.org/library/papers/29071215PubMed
1627107419Essential role for acid sphingomyelinase-inhibited autophagy in melanoma response to cisplatin.Oncotarget2016https://conductscience.org/library/papers/27107419PubMed
1723864953Drug resistance and the role of combination chemotherapy in improving patient outcomes.Int J Breast Cancer2013https://conductscience.org/library/papers/23864953PubMed
1816118219SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism.J Biol Chem2005https://conductscience.org/library/papers/16118219PubMed
1915141021Overexpression of glucosylceramide synthase and P-glycoprotein in cancer cells selected for resistance to natural product chemotherapy.Mol Cancer Ther2004https://conductscience.org/library/papers/15141021PubMed
2030043096Field template-based design and biological evaluation of new sphingosine kinase 1 inhibitors.Breast Cancer Res Treat2018https://conductscience.org/library/papers/30043096PubMed

See all 122 referencesDownload CSV of references

Cited by42

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.

PMIDTitleJournalYearIn PapersSource
42783271Function of HIF-1α in Regulating Sphingolipid Metabolism and Alleviating Oxidative Stress Damage in Callosobruchus chinensis Under Hypoxia.Insects2026https://conductscience.org/library/papers/42783271PubMed
42151473Spatial lipidomics with in situ segmentation for profiling doxorubicin drug effect of hepatoma carcinoma cell spheroids.Anal Bioanal Chem2026https://conductscience.org/library/papers/42151473PubMed
42004813A Rare Case Report of Immunoglobulin D Subtype Multiple Myeloma Complicated With Hyperlipidemia.Case Rep Hematol2026https://conductscience.org/library/papers/42004813PubMed
41977417Suppression of Glucosylceramide Synthase Reverses Drug Resistance in Cancer Cells Harboring Homozygous p53 Mutants.Int J Mol Sci2026https://conductscience.org/library/papers/41977417PubMed
41929516Sphingolipid-associated signature unveils TIMP1-driven temozolomide resistance and guides stratified therapy in glioblastoma.Front Immunol2026https://conductscience.org/library/papers/41929516PubMed
41795144SMPD1 as a Potential Prognostic Biomarker in Glioma Is Associated With an Immunosuppressive Microenvironment.CNS Neurosci Ther2026https://conductscience.org/library/papers/41795144PubMed
41415282Development and validation of a machine learning-driven mitochondrial gene signature for the diagnosis of breast cancer.Front Immunol2025https://conductscience.org/library/papers/41415282PubMed
41372954Heterogeneity of common carotid artery and abdominal aorta: an angle of sphingolipid metabolism in vascular smooth muscle cells.Biomed Eng Online2025https://conductscience.org/library/papers/41372954PubMed
41293266Multiomics analyses of human colorectal cancer reveal changes in mitochondrial metabolism associated with chemotherapy resistance.Front Oncol2025https://conductscience.org/library/papers/41293266PubMed
41190221Sphingolipid Metabolism Dysregulation Drives Immune Microenvironment Remodeling and Predicts Prognosis in Bladder Cancer.Int J Genomics2025https://conductscience.org/library/papers/41190221PubMed
40703332Nrf1 acts as a highly-conserved determinon for maintaining robust redox homeostasis in the eco-evo-devo process of life histories.Cell Stress2025https://conductscience.org/library/papers/40703332PubMed
40429618Differential Effects of Sphingolipids on Cell Death and Antioxidant Defenses in Type 1 and Type 2 Endometrial Cancer Cells.Int J Mol Sci2025https://conductscience.org/library/papers/40429618PubMed
40408281Cholangiocarcinoma cells direct fatty acids to support membrane synthesis and modulate macrophage phenotype.Hepatol Commun2025https://conductscience.org/library/papers/40408281PubMed
40332322Drug Resistance: The Role of Sphingolipid Metabolism.Int J Mol Sci2025https://conductscience.org/library/papers/40332322PubMed
40209098Impact of Excess Activin A on the Lipids, Metabolites, and Steroids of Adult Mouse Reproductive Organs.Endocrinology2025https://conductscience.org/library/papers/40209098PubMed
40088396Using ultrasound and microbubble to enhance the effects of conventional cancer therapies in clinical settings.Cancer Metastasis Rev2025https://conductscience.org/library/papers/40088396PubMed
39940937Identification of Lipid Species Signatures in FOLFOXIRI-Resistant Colorectal Cancer Cells.Int J Mol Sci2025https://conductscience.org/library/papers/39940937PubMed
39875359SPHK1 enhances olaparib resistance in ovarian cancer through the NFκB/NRF2/ferroptosis pathway.Cell Death Discov2025https://conductscience.org/library/papers/39875359PubMed
39796160Glucosylceramide Synthase Inhibition in Combination with Aripiprazole Sensitizes Hepatocellular Cancer Cells to Sorafenib and Doxorubicin.Int J Mol Sci2024https://conductscience.org/library/papers/39796160PubMed
39468100Leveraging ML for profiling lipidomic alterations in breast cancer tissues: a methodological perspective.Sci Rep2024https://conductscience.org/library/papers/39468100PubMed

See all 42 cited byDownload CSV of cited by

Genes30

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABCB15243PubTator's text mininghttps://conductscience.org/library/genes/5243NCBI Gene
ABL125PubTator's text mininghttps://conductscience.org/library/genes/25NCBI Gene
AGXT189PubTator's text mininghttps://conductscience.org/library/genes/189NCBI Gene
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
AKT2208PubTator's text mininghttps://conductscience.org/library/genes/208NCBI Gene
ASAH1427PubTator's text mininghttps://conductscience.org/library/genes/427NCBI Gene
BRAF673PubTator's text mininghttps://conductscience.org/library/genes/673NCBI Gene
CASP8841PubTator's text mininghttps://conductscience.org/library/genes/841NCBI Gene
CERK64781PubTator's text mininghttps://conductscience.org/library/genes/64781NCBI Gene
CTNNB11499PubTator's text mininghttps://conductscience.org/library/genes/1499NCBI Gene
ESR12099PubTator's text mininghttps://conductscience.org/library/genes/2099NCBI Gene
FAS355PubTator's text mininghttps://conductscience.org/library/genes/355NCBI Gene
FASLG356PubTator's text mininghttps://conductscience.org/library/genes/356NCBI Gene
GSK3B2932PubTator's text mininghttps://conductscience.org/library/genes/2932NCBI Gene
KDSR2531PubTator's text mininghttps://conductscience.org/library/genes/2531NCBI Gene
MTOR2475PubTator's text mininghttps://conductscience.org/library/genes/2475NCBI Gene
PDCD15133PubTator's text mininghttps://conductscience.org/library/genes/5133NCBI Gene
PTPA5524PubTator's text mininghttps://conductscience.org/library/genes/5524NCBI Gene
SMPD16609PubTator's text mininghttps://conductscience.org/library/genes/6609NCBI Gene
SMPD26610PubTator's text mininghttps://conductscience.org/library/genes/6610NCBI Gene

See all 30 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35004331

GET https://conductscience.org/api/papers/v1/35004331/references?page=2